Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock? | Collector
Quartz
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?
Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help
Quartz